SEATTLE--(BUSINESS WIRE)--#SpinalCord--According to Coherent Market Insights, the global spinal cord injury therapeutics market is estimated to be valued at US$ 6,630.7 million in 2020 and is expected to exhibit a CAGR of 6.7% during the forecast period (2020-2027).

Key Trends and Analysis of the Global Spinal Cord Injury Therapeutics Market:

Key companies are focusing on raising funds for research and development to develop treatment for spinal cord injury is expected to propel growth of the global spinal cord injury therapeutics market during the forecast period. For instance, in 2016, G-Therapeutics announced that they raised US$ 42 million by Series A investment round held by LSP, INKEF Capital, Gimv, and Wellington Partners. The funding was to develop novel neuro-stimulation therapy for people with spinal cord injuries (SCI).

Among regions, North America is expected to hold dominant position in the global spinal cord injury therapeutics market during the forecast period, owing to key players are focusing on research and development for the treatment of spinal cord injury. For instance, in 2019, Lineage Cell Therapeutics, Inc, a clinical-stage biotechnology company developing novel cellular therapies for unmet medical needs announced that, the SCiStar Study for the treatment of acute spinal cord injury (SCI) is currently in phase 3 clinical trials and showing positive results from the ongoing SCiStar study of OPC1, where the overall safety profile of OPC1 is exceptional with robust motor recovery in spinal cord injury.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4305

Key Market Takeaways:

The global spinal cord injury therapeutics market is expected to exhibit a CAGR of 6.7% during the forecast period, as key companies are focusing on research and development for the treatment of spinal cord injury. For instance, in 2018, Acorda Therapeutics completed its investigational clinical trial study on rapid administration, safety, and tolerability of AC105 in patients with acute spinal cord injury.

Competitive Landscape:

Key players operating in the global spinal cord injury therapeutics market include ReNetX Bio, InVivo Therapeutics Hldg, GTX Medical, Acorda Therapeutics, Lineage Cell Therapeutics, AbbVie Inc., Asterias Biotherapeutics, Inc, BioArctic, Kringle Pharma, Inc., Pfizer Inc., Pharmicell Co., Ltd., Bioaxone Biosciences, Inc., Vertex Pharmaceuticals Inc., Biogen Inc., RespireRx Phamaceuticals Inc., NervGen, Lannett Co Inc, Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories, MSN Laboratories Private Limited, Rising Pharmaceuticals, Inc., ScieGen Pharmaceuticals, Inc, and Cadila Healthcare Limited.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4305

Market Segmentation:

• Global Spinal Cord Injury Therapeutics Market, By Injury Type:
  • Complete Spinal Cord Injury
  • Incomplete Spinal Cord Injury
• Global Spinal Cord Injury Therapeutics Market, By Drug Type:
  • Corticosteroids
  • Muscle Relaxants and Anti-spastic drugs
  • Non-steroidal Anti-inflammatory drugs ( NSAID�S)
  • Anti-depressants
  • Anticonvulsants
  • Others
• Global Spinal Cord Injury Therapeutics Market, By Application:
  • Autonomic Dysreflexia (AD)
  • Spasticity & Inflammation
  • Pain Management
  • Depression
• Global Spinal Cord Injury Therapeutics Market, By Route of Administration :
  • Oral
  • Intravenous
• Global Spinal Cord Injury Therapeutics Market, By Distribution Channel :
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Spinal Cord Injury Therapeutics Market, By Region:
  • North America
    • By Country:
      • U.S.
      • Canada
  • Latin America
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country/Region:
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa

Related Market Intelligence Report:

Ischemia Reperfusion Injury Therapeutics Market, by Indication (Heart Injury, Kidney Injury, Intestine Injury, and Other Injury), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 � 2027

Read more: https://www.coherentmarketinsights.com/market-insight/ischemia-reperfusion-injury-therapeutics-market-4105

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.

Contacts

Mr. Shah

Senior Client Partner � Business Development

Coherent Market Insights

Phone:
US: +1-206-701-6702

UK: +44-020-8133-4027

Japan: +81-050-5539-1737

India: +91-848-285-0837

Email: [email protected]
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter